Genexine Inc.'s Form 4 filing
Rezolute, Inc. (RZLT) · filed Jul 28, 2021
- Accession no.
- 0001209191-21-048448
- Filed
- Jul 28, 2021, 5:24 PM ET
- Trade date
- Apr 26-Jul 23, 2019
- Filing delay
- 824 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $10.0M. It was filed 824 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Genexine Inc.CIK 0001834377 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2019 | Common Stock | CConversionAcquired | +56,818,175 | – | – | 56,818,175 | Direct | |
| Jul 23, 2019 | Common Stock | PPurchaseAcquired | +34,482,758 | $0.29 | +$9,999,999.82 | 91,300,933 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2019 | Common Stock | CConversionDisposed | −56,818,175 | $10.00 | −$12,500,000 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.